The TTS Global Initiative is the unique global community and platform of decision-makers and KOLs from all the core stakeholder groups in early-stage biomedical innovation; tech transfer, public research, patient organizations, foundations, venture capital, corporate venture, investment banks, start-ups, SMEs, big pharma, industry, and government.
If you need to access and build relationships with these key stakeholders in the Asian biotech sector, the TTS Asia is your key opportunity.
Designed with tech transfer officers at the center, the TTS summits are exclusive, high-level, interactive round-table expert discussions and debates where all participants are actively involved, where there are no pitches or presentations, and which provide an un-matched forum for building expertise, relationships, and doing business with all of the key stakeholder groups.
For ENTENTE member TTOs: If you plan to do business or develop collaborations in Asia, the TTS Asia is the ideal platform designed precisely to help you achieve your objectives.
Early registration until 5 November 2013, plus special reductions for ENTENTE members using the Partner Code ENTE13 for the lowest possible rates.
Register now at